Eliseo Serone

Statistics

Publications

Citations

145

H-Index

Active since

2012

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Wake Forest University

University of Utah

University of Rome Tor Vergata

University of Bari Aldo Moro

Eliseo Serone is an author at Icahn School of Medicine at Mount Sinai specializing in pharmacology, hematologic malignancy pharmacotherapy, and hematologic malignancy therapy.

ORCID

Publications per year

2012–2018

Publications

Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation

Giampiero Porcu, Eliseo Serone, Velia De Nardis et al. · PLoS ONE · 2015 · 44 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort

Marco Mirani, Giuseppe Favacchio, Eliseo Serone et al. · Pharmacological Research · 2018 · 31 citations

Medicine, Endocrinology, Internal Medicine +12

Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus

Domenico Frezza, Barbara Tolusso, Vincenzo Giambra et al. · Annals of the Rheumatic Diseases · 2012 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

John Mascarenhas, Josef T. Prchal, Alessandro Rambaldi et al. · Blood · 2016 · 28 citations

Pharmacy, Hematology, Pharmacotherapy +8

Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

Raajit K. Rampal, John Mascarenhas, Heidi Kosiorek et al. · Blood · 2016 · 14 citations

Medicine, Oncology, Pharmacology +12

1–5 of 5